nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapsone—MPO—Crohn's disease	0.214	0.727	CbGaD
Dapsone—MPO—Mesalazine—Crohn's disease	0.118	0.335	CbGbCtD
Dapsone—Sulfadiazine—Sulfasalazine—Crohn's disease	0.105	0.342	CrCrCtD
Dapsone—Sulfaphenazole—Sulfasalazine—Crohn's disease	0.105	0.342	CrCrCtD
Dapsone—Sulfapyridine—Sulfasalazine—Crohn's disease	0.0971	0.316	CrCrCtD
Dapsone—PTGS2—Crohn's disease	0.0801	0.273	CbGaD
Dapsone—PTGS2—Balsalazide—Crohn's disease	0.0509	0.145	CbGbCtD
Dapsone—PTGS1—Balsalazide—Crohn's disease	0.0429	0.122	CbGbCtD
Dapsone—PTGS2—Mesalazine—Crohn's disease	0.0407	0.116	CbGbCtD
Dapsone—PTGS1—Mesalazine—Crohn's disease	0.0343	0.0978	CbGbCtD
Dapsone—PTGS2—Sulfasalazine—Crohn's disease	0.0227	0.0647	CbGbCtD
Dapsone—PTGS1—Sulfasalazine—Crohn's disease	0.0192	0.0546	CbGbCtD
Dapsone—MPO—superior mesenteric artery—Crohn's disease	0.0143	0.591	CbGeAlD
Dapsone—CYP3A5—Sulfasalazine—Crohn's disease	0.0115	0.0328	CbGbCtD
Dapsone—CYP2C19—Prednisone—Crohn's disease	0.00742	0.0212	CbGbCtD
Dapsone—CYP3A4—Prednisone—Crohn's disease	0.00359	0.0102	CbGbCtD
Dapsone—Pulmonary eosinophilia—Mesalazine—Crohn's disease	0.00176	0.154	CcSEcCtD
Dapsone—Lupus-like syndrome—Mesalazine—Crohn's disease	0.00137	0.119	CcSEcCtD
Dapsone—CYP2C18—mammalian vulva—Crohn's disease	0.000791	0.0328	CbGeAlD
Dapsone—Nerve injury—Prednisone—Crohn's disease	0.000781	0.0682	CcSEcCtD
Dapsone—FMO3—mammalian vulva—Crohn's disease	0.000761	0.0315	CbGeAlD
Dapsone—CYP2C18—digestive system—Crohn's disease	0.000694	0.0288	CbGeAlD
Dapsone—Nephrotic syndrome—Mesalazine—Crohn's disease	0.000667	0.0582	CcSEcCtD
Dapsone—MPO—IL23-mediated signaling events—IL18RAP—Crohn's disease	0.000656	0.0568	CbGpPWpGaD
Dapsone—MPO—IL23-mediated signaling events—IL23A—Crohn's disease	0.000585	0.0506	CbGpPWpGaD
Dapsone—MPO—epithelium—Crohn's disease	0.000578	0.024	CbGeAlD
Dapsone—MPO—skin of body—Crohn's disease	0.00055	0.0228	CbGeAlD
Dapsone—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX4—Crohn's disease	0.000544	0.047	CbGpPWpGaD
Dapsone—PTGS2—gall bladder—Crohn's disease	0.000507	0.021	CbGeAlD
Dapsone—PTGS2—mouth—Crohn's disease	0.000451	0.0187	CbGeAlD
Dapsone—MPO—lymphoid tissue—Crohn's disease	0.000445	0.0185	CbGeAlD
Dapsone—MPO—digestive system—Crohn's disease	0.00044	0.0182	CbGeAlD
Dapsone—Albuminuria—Mesalazine—Crohn's disease	0.000432	0.0377	CcSEcCtD
Dapsone—FMO3—lymph node—Crohn's disease	0.000381	0.0158	CbGeAlD
Dapsone—Proteinuria—Mesalazine—Crohn's disease	0.000367	0.032	CcSEcCtD
Dapsone—Pancreatitis—Mercaptopurine—Crohn's disease	0.000365	0.0319	CcSEcCtD
Dapsone—Protein urine present—Mesalazine—Crohn's disease	0.000362	0.0316	CcSEcCtD
Dapsone—Skin exfoliation—Mesalazine—Crohn's disease	0.000308	0.0269	CcSEcCtD
Dapsone—CYP2C19—digestive system—Crohn's disease	0.000295	0.0122	CbGeAlD
Dapsone—PTGS1—epithelium—Crohn's disease	0.000274	0.0114	CbGeAlD
Dapsone—MPO—IL23-mediated signaling events—IL17A—Crohn's disease	0.000274	0.0237	CbGpPWpGaD
Dapsone—PTGS1—smooth muscle tissue—Crohn's disease	0.000264	0.011	CbGeAlD
Dapsone—PTGS2—epithelium—Crohn's disease	0.000262	0.0109	CbGeAlD
Dapsone—PTGS1—skin of body—Crohn's disease	0.000261	0.0108	CbGeAlD
Dapsone—MPO—IL23-mediated signaling events—IL12B—Crohn's disease	0.000255	0.022	CbGpPWpGaD
Dapsone—PTGS2—smooth muscle tissue—Crohn's disease	0.000253	0.0105	CbGeAlD
Dapsone—MPO—lymph node—Crohn's disease	0.000251	0.0104	CbGeAlD
Dapsone—PTGS2—skin of body—Crohn's disease	0.000249	0.0103	CbGeAlD
Dapsone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CREM—Crohn's disease	0.000248	0.0215	CbGpPWpGaD
Dapsone—MPO—Folate Metabolism—GPX4—Crohn's disease	0.000246	0.0213	CbGpPWpGaD
Dapsone—PTGS1—mammalian vulva—Crohn's disease	0.000238	0.00986	CbGeAlD
Dapsone—CYP3A5—digestive system—Crohn's disease	0.000232	0.00963	CbGeAlD
Dapsone—CYP2C9—digestive system—Crohn's disease	0.000229	0.00948	CbGeAlD
Dapsone—CYP2E1—lymphoid tissue—Crohn's disease	0.000219	0.00909	CbGeAlD
Dapsone—Pancreatitis—Azathioprine—Crohn's disease	0.000218	0.019	CcSEcCtD
Dapsone—CYP2E1—digestive system—Crohn's disease	0.000217	0.00898	CbGeAlD
Dapsone—Nasopharyngitis—Mesalazine—Crohn's disease	0.000209	0.0183	CcSEcCtD
Dapsone—PTGS1—digestive system—Crohn's disease	0.000209	0.00865	CbGeAlD
Dapsone—FMO3—SIDS Susceptibility Pathways—CREM—Crohn's disease	0.000208	0.018	CbGpPWpGaD
Dapsone—Influenza—Mesalazine—Crohn's disease	0.000202	0.0177	CcSEcCtD
Dapsone—Sulfamethazine—ALB—Crohn's disease	0.000202	0.316	CrCbGaD
Dapsone—PTGS2—lymphoid tissue—Crohn's disease	0.000202	0.00837	CbGeAlD
Dapsone—PTGS2—digestive system—Crohn's disease	0.0002	0.00827	CbGeAlD
Dapsone—Pancreatitis—Mesalazine—Crohn's disease	0.000198	0.0173	CcSEcCtD
Dapsone—Sulfamerazine—ALB—Crohn's disease	0.000198	0.309	CrCbGaD
Dapsone—MPO—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000195	0.0169	CbGpPWpGaD
Dapsone—MPO—IL23-mediated signaling events—IL18—Crohn's disease	0.000187	0.0162	CbGpPWpGaD
Dapsone—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000185	0.0161	CcSEcCtD
Dapsone—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000177	0.0154	CcSEcCtD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—Crohn's disease	0.000176	0.0152	CbGpPWpGaD
Dapsone—CYP3A4—digestive system—Crohn's disease	0.000174	0.00723	CbGeAlD
Dapsone—Sinusitis—Mesalazine—Crohn's disease	0.000169	0.0148	CcSEcCtD
Dapsone—Body temperature increased—Mercaptopurine—Crohn's disease	0.000168	0.0146	CcSEcCtD
Dapsone—Skin exfoliation—Prednisone—Crohn's disease	0.000163	0.0142	CcSEcCtD
Dapsone—NAT2—Metapathway biotransformation—GPX4—Crohn's disease	0.000162	0.0141	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CREM—Crohn's disease	0.000161	0.0139	CbGpPWpGaD
Dapsone—Pharyngitis—Mesalazine—Crohn's disease	0.000161	0.014	CcSEcCtD
Dapsone—Sulfamethizole—ALB—Crohn's disease	0.000153	0.24	CrCbGaD
Dapsone—Tinnitus—Mesalazine—Crohn's disease	0.000151	0.0132	CcSEcCtD
Dapsone—Erythema—Mesalazine—Crohn's disease	0.000141	0.0123	CcSEcCtD
Dapsone—Vomiting—Mercaptopurine—Crohn's disease	0.000135	0.0118	CcSEcCtD
Dapsone—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000135	0.0117	CbGpPWpGaD
Dapsone—Vision blurred—Mesalazine—Crohn's disease	0.000133	0.0116	CcSEcCtD
Dapsone—Vertigo—Mesalazine—Crohn's disease	0.000127	0.0111	CcSEcCtD
Dapsone—Nausea—Mercaptopurine—Crohn's disease	0.000126	0.011	CcSEcCtD
Dapsone—PTGS1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000126	0.0109	CbGpPWpGaD
Dapsone—Cough—Mesalazine—Crohn's disease	0.000123	0.0107	CcSEcCtD
Dapsone—MPO—Vitamin B12 Metabolism—CRP—Crohn's disease	0.000121	0.0105	CbGpPWpGaD
Dapsone—Psychotic disorder—Prednisone—Crohn's disease	0.000121	0.0106	CcSEcCtD
Dapsone—PTGS1—lymph node—Crohn's disease	0.000119	0.00494	CbGeAlD
Dapsone—FMO3—Metapathway biotransformation—GPX4—Crohn's disease	0.000117	0.0102	CbGpPWpGaD
Dapsone—MPO—IL23-mediated signaling events—TYK2—Crohn's disease	0.000117	0.0101	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—TAB1—Crohn's disease	0.000116	0.0101	CbGpPWpGaD
Dapsone—PTGS2—lymph node—Crohn's disease	0.000114	0.00472	CbGeAlD
Dapsone—Tachycardia—Mesalazine—Crohn's disease	0.000112	0.0098	CcSEcCtD
Dapsone—MPO—IL23-mediated signaling events—JAK2—Crohn's disease	0.000112	0.00966	CbGpPWpGaD
Dapsone—MPO—Vitamin B12 Metabolism—ICAM1—Crohn's disease	0.000111	0.00964	CbGpPWpGaD
Dapsone—MPO—IL23-mediated signaling events—IFNG—Crohn's disease	0.00011	0.00948	CbGpPWpGaD
Dapsone—PTGS1—Overview of nanoparticle effects—CRP—Crohn's disease	0.000109	0.00945	CbGpPWpGaD
Dapsone—Muscular weakness—Prednisone—Crohn's disease	0.000109	0.00953	CcSEcCtD
Dapsone—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000107	0.00925	CbGpPWpGaD
Dapsone—MPO—IL23-mediated signaling events—CD4—Crohn's disease	0.000106	0.00915	CbGpPWpGaD
Dapsone—Pancreatitis—Prednisone—Crohn's disease	0.000105	0.00916	CcSEcCtD
Dapsone—Insomnia—Mesalazine—Crohn's disease	0.000104	0.00908	CcSEcCtD
Dapsone—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000103	0.00901	CcSEcCtD
Dapsone—Body temperature increased—Azathioprine—Crohn's disease	9.98e-05	0.00871	CcSEcCtD
Dapsone—Abdominal pain—Azathioprine—Crohn's disease	9.98e-05	0.00871	CcSEcCtD
Dapsone—PTGS2—Arachidonic acid metabolism—GPX4—Crohn's disease	9.97e-05	0.00863	CbGpPWpGaD
Dapsone—MPO—Folate Metabolism—CRP—Crohn's disease	9.85e-05	0.00853	CbGpPWpGaD
Dapsone—MPO—IL23-mediated signaling events—IL1B—Crohn's disease	9.77e-05	0.00845	CbGpPWpGaD
Dapsone—Gastrointestinal pain—Mesalazine—Crohn's disease	9.4e-05	0.00821	CcSEcCtD
Dapsone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—Crohn's disease	9.35e-05	0.0081	CbGpPWpGaD
Dapsone—Neuropathy peripheral—Prednisone—Crohn's disease	9.35e-05	0.00816	CcSEcCtD
Dapsone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Crohn's disease	9.35e-05	0.00809	CbGpPWpGaD
Dapsone—MPO—Vitamin B12 Metabolism—ALB—Crohn's disease	9.28e-05	0.00803	CbGpPWpGaD
Dapsone—Abdominal pain—Mesalazine—Crohn's disease	9.09e-05	0.00794	CcSEcCtD
Dapsone—Body temperature increased—Mesalazine—Crohn's disease	9.09e-05	0.00794	CcSEcCtD
Dapsone—MPO—Folate Metabolism—ICAM1—Crohn's disease	9.06e-05	0.00784	CbGpPWpGaD
Dapsone—PTGS2—Overview of nanoparticle effects—CRP—Crohn's disease	8.67e-05	0.0075	CbGpPWpGaD
Dapsone—Sulfamethoxazole—ALB—Crohn's disease	8.6e-05	0.135	CrCbGaD
Dapsone—MPO—Vitamin B12 Metabolism—IFNG—Crohn's disease	8.47e-05	0.00733	CbGpPWpGaD
Dapsone—MPO—IL23-mediated signaling events—STAT3—Crohn's disease	8.19e-05	0.00709	CbGpPWpGaD
Dapsone—CYP2C8—Arachidonic acid metabolism—GPX4—Crohn's disease	8.11e-05	0.00702	CbGpPWpGaD
Dapsone—Vomiting—Azathioprine—Crohn's disease	8.03e-05	0.00701	CcSEcCtD
Dapsone—PTGS1—Selenium Micronutrient Network—GPX4—Crohn's disease	7.99e-05	0.00691	CbGpPWpGaD
Dapsone—Headache—Azathioprine—Crohn's disease	7.91e-05	0.00691	CcSEcCtD
Dapsone—MPO—Selenium Micronutrient Network—CRP—Crohn's disease	7.83e-05	0.00678	CbGpPWpGaD
Dapsone—MPO—Vitamin B12 Metabolism—IL1B—Crohn's disease	7.56e-05	0.00654	CbGpPWpGaD
Dapsone—MPO—Folate Metabolism—ALB—Crohn's disease	7.55e-05	0.00654	CbGpPWpGaD
Dapsone—Nausea—Azathioprine—Crohn's disease	7.5e-05	0.00655	CcSEcCtD
Dapsone—Erythema—Prednisone—Crohn's disease	7.46e-05	0.00651	CcSEcCtD
Dapsone—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	7.32e-05	0.00634	CbGpPWpGaD
Dapsone—Vomiting—Mesalazine—Crohn's disease	7.31e-05	0.00638	CcSEcCtD
Dapsone—CYP2C19—Arachidonic acid metabolism—GPX4—Crohn's disease	7.24e-05	0.00627	CbGpPWpGaD
Dapsone—Headache—Mesalazine—Crohn's disease	7.2e-05	0.00629	CcSEcCtD
Dapsone—MPO—Selenium Micronutrient Network—ICAM1—Crohn's disease	7.2e-05	0.00623	CbGpPWpGaD
Dapsone—CYP2C18—Metapathway biotransformation—GPX4—Crohn's disease	7.15e-05	0.00619	CbGpPWpGaD
Dapsone—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	7.1e-05	0.00615	CbGpPWpGaD
Dapsone—MPO—IL23-mediated signaling events—TNF—Crohn's disease	7.09e-05	0.00613	CbGpPWpGaD
Dapsone—Vision blurred—Prednisone—Crohn's disease	7.03e-05	0.00613	CcSEcCtD
Dapsone—MPO—Folate Metabolism—IFNG—Crohn's disease	6.89e-05	0.00597	CbGpPWpGaD
Dapsone—Nausea—Mesalazine—Crohn's disease	6.83e-05	0.00596	CcSEcCtD
Dapsone—Vertigo—Prednisone—Crohn's disease	6.7e-05	0.00585	CcSEcCtD
Dapsone—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	6.6e-05	0.00571	CbGpPWpGaD
Dapsone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	6.55e-05	0.00567	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	6.34e-05	0.00549	CbGpPWpGaD
Dapsone—MPO—Folate Metabolism—IL1B—Crohn's disease	6.15e-05	0.00532	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—IL10—Crohn's disease	6.14e-05	0.00532	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	6.09e-05	0.00527	CbGpPWpGaD
Dapsone—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	6.07e-05	0.00526	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	6.05e-05	0.00524	CbGpPWpGaD
Dapsone—MPO—Selenium Micronutrient Network—ALB—Crohn's disease	6e-05	0.00519	CbGpPWpGaD
Dapsone—Tachycardia—Prednisone—Crohn's disease	5.94e-05	0.00518	CcSEcCtD
Dapsone—MPO—IL23-mediated signaling events—IL6—Crohn's disease	5.72e-05	0.00495	CbGpPWpGaD
Dapsone—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	5.64e-05	0.00488	CbGpPWpGaD
Dapsone—Insomnia—Prednisone—Crohn's disease	5.5e-05	0.0048	CcSEcCtD
Dapsone—MPO—C-MYB transcription factor network—CD4—Crohn's disease	5.49e-05	0.00475	CbGpPWpGaD
Dapsone—MPO—Vitamin B12 Metabolism—TNF—Crohn's disease	5.48e-05	0.00475	CbGpPWpGaD
Dapsone—MPO—Selenium Micronutrient Network—IFNG—Crohn's disease	5.48e-05	0.00474	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—PTGS2—Crohn's disease	5.45e-05	0.00472	CbGpPWpGaD
Dapsone—MPO—Selenium Micronutrient Network—PTGS2—Crohn's disease	5.25e-05	0.00454	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	5.11e-05	0.00443	CbGpPWpGaD
Dapsone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	5.08e-05	0.0044	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	5.02e-05	0.00434	CbGpPWpGaD
Dapsone—Gastrointestinal pain—Prednisone—Crohn's disease	4.98e-05	0.00434	CcSEcCtD
Dapsone—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	4.94e-05	0.00428	CbGpPWpGaD
Dapsone—MPO—Selenium Micronutrient Network—IL1B—Crohn's disease	4.88e-05	0.00423	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	4.84e-05	0.00419	CbGpPWpGaD
Dapsone—Body temperature increased—Prednisone—Crohn's disease	4.81e-05	0.0042	CcSEcCtD
Dapsone—Abdominal pain—Prednisone—Crohn's disease	4.81e-05	0.0042	CcSEcCtD
Dapsone—CYP3A7—Metapathway biotransformation—GPX4—Crohn's disease	4.76e-05	0.00412	CbGpPWpGaD
Dapsone—NAT2—Metabolism—PLA2G4F—Crohn's disease	4.54e-05	0.00393	CbGpPWpGaD
Dapsone—MPO—Folate Metabolism—TNF—Crohn's disease	4.46e-05	0.00386	CbGpPWpGaD
Dapsone—MPO—Vitamin B12 Metabolism—IL6—Crohn's disease	4.42e-05	0.00383	CbGpPWpGaD
Dapsone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	4.32e-05	0.00374	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	4.24e-05	0.00367	CbGpPWpGaD
Dapsone—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	3.99e-05	0.00345	CbGpPWpGaD
Dapsone—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	3.92e-05	0.0034	CbGpPWpGaD
Dapsone—Vomiting—Prednisone—Crohn's disease	3.87e-05	0.00338	CcSEcCtD
Dapsone—NAT2—Metabolism—MTMR3—Crohn's disease	3.86e-05	0.00334	CbGpPWpGaD
Dapsone—Headache—Prednisone—Crohn's disease	3.81e-05	0.00333	CcSEcCtD
Dapsone—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	3.78e-05	0.00327	CbGpPWpGaD
Dapsone—Nausea—Prednisone—Crohn's disease	3.61e-05	0.00316	CcSEcCtD
Dapsone—MPO—Folate Metabolism—IL6—Crohn's disease	3.6e-05	0.00312	CbGpPWpGaD
Dapsone—MPO—Selenium Micronutrient Network—TNF—Crohn's disease	3.54e-05	0.00307	CbGpPWpGaD
Dapsone—CYP2E1—Metapathway biotransformation—GPX4—Crohn's disease	3.44e-05	0.00298	CbGpPWpGaD
Dapsone—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	3.44e-05	0.00297	CbGpPWpGaD
Dapsone—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	3.38e-05	0.00292	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	3.36e-05	0.00291	CbGpPWpGaD
Dapsone—FMO3—Metabolism—PLA2G4F—Crohn's disease	3.28e-05	0.00284	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—IL1B—Crohn's disease	3.22e-05	0.00279	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	3.2e-05	0.00277	CbGpPWpGaD
Dapsone—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	3.17e-05	0.00274	CbGpPWpGaD
Dapsone—NAT2—Metabolism—FADS1—Crohn's disease	3.01e-05	0.0026	CbGpPWpGaD
Dapsone—CYP2C8—Metapathway biotransformation—GPX4—Crohn's disease	2.98e-05	0.00258	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	2.94e-05	0.00255	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.89e-05	0.0025	CbGpPWpGaD
Dapsone—MPO—Selenium Micronutrient Network—IL6—Crohn's disease	2.86e-05	0.00248	CbGpPWpGaD
Dapsone—NAT2—Metabolism—GPX4—Crohn's disease	2.82e-05	0.00244	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	2.8e-05	0.00242	CbGpPWpGaD
Dapsone—FMO3—Metabolism—MTMR3—Crohn's disease	2.79e-05	0.00242	CbGpPWpGaD
Dapsone—NAT2—Metabolism—GCKR—Crohn's disease	2.72e-05	0.00236	CbGpPWpGaD
Dapsone—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	2.66e-05	0.0023	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	2.6e-05	0.00225	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	2.54e-05	0.0022	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.46e-05	0.00213	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	2.46e-05	0.00213	CbGpPWpGaD
Dapsone—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	2.42e-05	0.0021	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.34e-05	0.00202	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	2.34e-05	0.00202	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.3e-05	0.00199	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	2.24e-05	0.00194	CbGpPWpGaD
Dapsone—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	2.18e-05	0.00189	CbGpPWpGaD
Dapsone—FMO3—Metabolism—FADS1—Crohn's disease	2.18e-05	0.00188	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	2.15e-05	0.00186	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	2.07e-05	0.00179	CbGpPWpGaD
Dapsone—FMO3—Metabolism—GPX4—Crohn's disease	2.04e-05	0.00176	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PLA2G4F—Crohn's disease	2e-05	0.00173	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	2e-05	0.00173	CbGpPWpGaD
Dapsone—FMO3—Metabolism—GCKR—Crohn's disease	1.97e-05	0.0017	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.95e-05	0.00169	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	1.95e-05	0.00169	CbGpPWpGaD
Dapsone—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	1.95e-05	0.00168	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	1.93e-05	0.00167	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	1.93e-05	0.00167	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.92e-05	0.00166	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.89e-05	0.00163	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.87e-05	0.00162	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	1.85e-05	0.0016	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	1.81e-05	0.00157	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.79e-05	0.00155	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	1.78e-05	0.00154	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	1.78e-05	0.00154	CbGpPWpGaD
Dapsone—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	1.78e-05	0.00154	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—MTMR3—Crohn's disease	1.7e-05	0.00147	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.67e-05	0.00144	CbGpPWpGaD
Dapsone—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	1.6e-05	0.00138	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.59e-05	0.00138	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	1.59e-05	0.00137	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.52e-05	0.00132	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	1.52e-05	0.00132	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	1.45e-05	0.00126	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.42e-05	0.00123	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.42e-05	0.00123	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	1.41e-05	0.00122	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	1.33e-05	0.00115	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—FADS1—Crohn's disease	1.32e-05	0.00115	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	1.31e-05	0.00113	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.29e-05	0.00112	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PLA2G4F—Crohn's disease	1.29e-05	0.00112	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	1.25e-05	0.00109	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—GPX4—Crohn's disease	1.24e-05	0.00107	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.24e-05	0.00107	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—GCKR—Crohn's disease	1.2e-05	0.00104	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	1.17e-05	0.00101	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.16e-05	0.001	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	1.15e-05	0.000996	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—MTMR3—Crohn's disease	1.13e-05	0.000978	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.1e-05	0.000956	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—MTMR3—Crohn's disease	1.1e-05	0.000948	CbGpPWpGaD
Dapsone—PTGS2—Disease—RSPO3—Crohn's disease	1.07e-05	0.000924	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.03e-05	0.000896	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—PLA2G4F—Crohn's disease	1.02e-05	0.000885	CbGpPWpGaD
Dapsone—PTGS2—Disease—SEL1L—Crohn's disease	1.01e-05	0.000876	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.01e-05	0.000872	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	9.63e-06	0.000833	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	9.61e-06	0.000832	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	9.43e-06	0.000817	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	9.29e-06	0.000804	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	9.1e-06	0.000788	CbGpPWpGaD
Dapsone—PTGS2—Disease—LTF—Crohn's disease	9.08e-06	0.000786	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—FADS1—Crohn's disease	8.81e-06	0.000762	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—MTMR3—Crohn's disease	8.7e-06	0.000753	CbGpPWpGaD
Dapsone—NAT2—Metabolism—ALB—Crohn's disease	8.66e-06	0.00075	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—FADS1—Crohn's disease	8.54e-06	0.000739	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	8.32e-06	0.00072	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—GPX4—Crohn's disease	8.25e-06	0.000714	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—MTMR3—Crohn's disease	8.19e-06	0.000709	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—MTMR3—Crohn's disease	8.17e-06	0.000707	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—GPX4—Crohn's disease	7.99e-06	0.000692	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—GCKR—Crohn's disease	7.96e-06	0.000689	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—GCKR—Crohn's disease	7.72e-06	0.000668	CbGpPWpGaD
Dapsone—NAT2—Metabolism—PTGS2—Crohn's disease	7.58e-06	0.000656	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	7.43e-06	0.000643	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	7.35e-06	0.000636	CbGpPWpGaD
Dapsone—PTGS2—Disease—GCKR—Crohn's disease	7.32e-06	0.000633	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—MTMR3—Crohn's disease	7.08e-06	0.000612	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—FADS1—Crohn's disease	6.78e-06	0.000586	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	6.77e-06	0.000586	CbGpPWpGaD
Dapsone—PTGS2—Disease—SLC11A1—Crohn's disease	6.47e-06	0.00056	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—FADS1—Crohn's disease	6.38e-06	0.000552	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—FADS1—Crohn's disease	6.37e-06	0.000551	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—GPX4—Crohn's disease	6.34e-06	0.000549	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—MTMR3—Crohn's disease	6.32e-06	0.000547	CbGpPWpGaD
Dapsone—FMO3—Metabolism—ALB—Crohn's disease	6.26e-06	0.000542	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	6.19e-06	0.000536	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—GCKR—Crohn's disease	6.13e-06	0.00053	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GPX4—Crohn's disease	5.97e-06	0.000517	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GPX4—Crohn's disease	5.96e-06	0.000516	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GCKR—Crohn's disease	5.77e-06	0.000499	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—MTMR3—Crohn's disease	5.76e-06	0.000498	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GCKR—Crohn's disease	5.76e-06	0.000498	CbGpPWpGaD
Dapsone—PTGS2—Disease—RBX1—Crohn's disease	5.55e-06	0.00048	CbGpPWpGaD
Dapsone—PTGS2—Disease—HSPA1B—Crohn's disease	5.55e-06	0.00048	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.52e-06	0.000477	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—FADS1—Crohn's disease	5.51e-06	0.000477	CbGpPWpGaD
Dapsone—FMO3—Metabolism—PTGS2—Crohn's disease	5.48e-06	0.000474	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GPX4—Crohn's disease	5.16e-06	0.000447	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GCKR—Crohn's disease	4.99e-06	0.000432	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—FADS1—Crohn's disease	4.92e-06	0.000426	CbGpPWpGaD
Dapsone—PTGS2—Disease—UBE2D1—Crohn's disease	4.86e-06	0.000421	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.83e-06	0.000418	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GPX4—Crohn's disease	4.61e-06	0.000399	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—FADS1—Crohn's disease	4.49e-06	0.000388	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	4.47e-06	0.000387	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GCKR—Crohn's disease	4.45e-06	0.000385	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.38e-06	0.000379	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GPX4—Crohn's disease	4.2e-06	0.000364	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GCKR—Crohn's disease	4.06e-06	0.000351	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—ALB—Crohn's disease	3.81e-06	0.00033	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—MTMR3—Crohn's disease	3.8e-06	0.000329	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.56e-06	0.000308	CbGpPWpGaD
Dapsone—PTGS2—Disease—SMAD3—Crohn's disease	3.48e-06	0.000301	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—PTGS2—Crohn's disease	3.34e-06	0.000289	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.18e-06	0.000275	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.12e-06	0.00027	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—FADS1—Crohn's disease	2.96e-06	0.000256	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.9e-06	0.000251	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.78e-06	0.000241	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GPX4—Crohn's disease	2.77e-06	0.00024	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GCKR—Crohn's disease	2.68e-06	0.000232	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.54e-06	0.00022	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—ALB—Crohn's disease	2.53e-06	0.000219	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—ALB—Crohn's disease	2.46e-06	0.000213	CbGpPWpGaD
Dapsone—PTGS2—Disease—TYK2—Crohn's disease	2.27e-06	0.000196	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—PTGS2—Crohn's disease	2.22e-06	0.000192	CbGpPWpGaD
Dapsone—PTGS2—Disease—JAK2—Crohn's disease	2.16e-06	0.000187	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—PTGS2—Crohn's disease	2.15e-06	0.000186	CbGpPWpGaD
Dapsone—PTGS2—Disease—CD4—Crohn's disease	2.05e-06	0.000178	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—ALB—Crohn's disease	1.95e-06	0.000169	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—ALB—Crohn's disease	1.84e-06	0.000159	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—ALB—Crohn's disease	1.83e-06	0.000159	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—PTGS2—Crohn's disease	1.61e-06	0.000139	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—PTGS2—Crohn's disease	1.6e-06	0.000139	CbGpPWpGaD
Dapsone—PTGS2—Disease—STAT3—Crohn's disease	1.59e-06	0.000138	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ALB—Crohn's disease	1.59e-06	0.000137	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ALB—Crohn's disease	1.42e-06	0.000123	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—PTGS2—Crohn's disease	1.39e-06	0.00012	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ALB—Crohn's disease	1.29e-06	0.000112	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—PTGS2—Crohn's disease	1.24e-06	0.000107	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.13e-06	9.78e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—IL6—Crohn's disease	1.11e-06	9.61e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ALB—Crohn's disease	8.52e-07	7.37e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—PTGS2—Crohn's disease	7.45e-07	6.45e-05	CbGpPWpGaD
